Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Renée D. Galá
CEORenée D. Galá
Employees
2,890
Employees2,890
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,890
Employees2,890

JAZZ Key Statistics

Market cap
14.84B
Market cap14.84B
Price-Earnings ratio
-12,852.72
Price-Earnings ratio-12,852.72
Dividend yield
Dividend yield
Average volume
899.19K
Average volume899.19K
High today
High today
Low today
Low today
Open price
$235.36
Open price$235.36
Volume
0.00
Volume0.00
52 Week high
$243.32
52 Week high$243.32
52 Week low
$105.00
52 Week low$105.00

Stock Snapshot

The current Jazz Pharmaceuticals(JAZZ) stock price is $236.49, with a market capitalization of 14.84B. The stock trades at a price-to-earnings (P/E) ratio of -12852.72.

Jazz Pharmaceuticals(JAZZ) stock opened on 2026-06-01 at $235.36. The price climbed to — and dipped to —.

The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 0, compared to an average daily volume of 899.19K.

In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $243.32 and a 52-week low of $105.00.

In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $243.32 and a 52-week low of $105.00.

JAZZ News

Simply Wall St 2d
A Look At Jazz Pharmaceuticals Valuation After A Strong Multi Period Share Price Run

Advertisement Recent performance context Jazz Pharmaceuticals (JAZZ) has drawn investor interest after solid recent returns, with the stock up roughly 18% ove...

A Look At Jazz Pharmaceuticals Valuation After A Strong Multi Period Share Price Run
TipRanks 3d
Jazz Pharmaceuticals announces planned board leadership transition

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 4d
Insiders Make Major Cash Move at Jazz Pharmaceuticals

New insider activity at Jazz Pharmaceuticals ( (JAZZ) ) has taken place on May 27, 2026. Unlock trusted, data-backed investing tools with TipRanks Premium, fro...

Analyst ratings

85%

of 20 ratings
Buy
85%
Hold
5%
Sell
10%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.